Zyus Life Sciences amends $100,000 promissory note, extends maturity to Aug. 24, 2027

Reuters2026/09/09 22:58

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Zyus disclosed $1.95 million of advances across nine tranches under a secured loan facility at its wholly owned subsidiary.
Facility provides up to $2 million of debt financing from existing stakeholders to support Phase 2a clinical work.
A term loan entered in 2021 fell into default in Q2 2026 due to missed principal payments.
Cure process agreed on July 9, 2026; default remedied post-June 30, 2026 with all milestones met.
A $4.4 million 2026 promissory note to its landlord became delinquent from May 1, 2026; missed lease payments also flagged.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zyus Life Sciences Corporation published the original content used to generate this news brief via CNW (Ref. ID: 202609091857CANADANWCANADAPR_C0722) on September 09, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Zyus Life Sciences amends $100,000 promissory note, extends maturity to Aug. 24, 2027

You may also like

Crypto prices